Pathobiological implications of MUC4 in non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 8, Issue 4, 2013, Pages 398-407

  Majhi, Prabin Dhangada ^a   Lakshmanan, Imayavaramban ^a   Ponnusamy, Moorthy P ^a   Jain, Maneesh ^a   Das, Srustidhar ^a   Kaur, Sukhwinder ^a   Shimizu, Su Tomohiro ^a   West, William W ^a   Johansson, Sonny L ^a,b   Smith, Lynette M ^b   Yu, Fang ^b   Rolle, Cleo E ^c   Sharma, Poonam ^d   Carey, George B ^c   Batra, Surinder K ^a,b   Ganti, Apar Kishor ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

EMT; Invasion; Lung cancer; Motility; MUC4; p53

Indexed keywords

CYCLIN D1; CYCLIN E; FOCAL ADHESION KINASE; MUCIN 4; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; METASTASIS; OVERALL SURVIVAL; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION;

EID: 84875392649     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182829e06     Document Type: Article

References (28)

1. Chaturvedi P, Singh AP, Chakraborty S, et al. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res 2008;68:2065-2070
2. Voynow JA. What does mucin have to do with lung disease? Paediatr Respir Rev 2002;3:98-103
3. Ogata S, Uehara H, Chen A, et al. Mucin gene expression in colonic tissues and cell lines. Cancer Res 1992;52:5971-5978
4. Gipson IK, Ho SB, Spurr-Michaud SJ, et al. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod 1997;56:999-1011
5. Gipson IK, Inatomi T. Cellular origin of mucins of the ocular surface tear film. Adv Exp Med Biol 1998;438:221-227
6. Singh AP, Chauhan SC, Bafna S, et al. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 2006;66:421-429
7. Lin J, Tsuprun V, Kawano H, et al. Characterization of mucins in human middle ear and Eustachian tube. Am J Physiol Lung Cell Mol Physiol 2001;280:L1157-L1167
8. Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 2005;31:301-316
9. Torres MP, Ponnusamy MP, Lakshmanan I, Batra SK. Immunopathogenesis of ovarian cancer. Minerva Med 2009;100:385-400
10. Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapy. Biochim Biophys Acta 2011;1815:224-240
11. Carraway KL 3rd, Rossi EA, Komatsu M, et al. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem 1999;274:5263-5266
12. Buisine MP, Devisme L, Copin MC, et al. Developmental mucin gene expression in the human respiratory tract. Am J Respir Cell Mol Biol 1999;20:209-218
13. Copin MC, Devisme L, Buisine MP, et al. From normal respiratory mucosa to epidermoid carcinoma: Expression of human mucin genes. Int J Cancer 2000;86:162-168
14. Copin MC, Buisine MP, Leteurtre E, et al. Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas. Hum Pathol 2001;32:274-281
15. Kwon KY, Ro JY, Singhal N, et al. MUC4 expression in non-small cell lung carcinomas: Relationship to tumor histology and patient survival. Arch Pathol Lab Med 2007;131:593-598
16. Tsutsumida H, Goto M, Kitajima S, et al. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 2007;55:195-203
17. Chaturvedi P, Singh AP, Moniaux N, et al. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 2007;5:309-320
18. Moniaux N, Chaturvedi P, Varshney GC, et al. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. Br J Cancer 2007;97:345-357
19. Manning BD, Cantley LC. AKT/PKB signaling: Navigating downstream. Cell 2007;129:1261-1274
20. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001;3:973-982
21. Brockbank EC, Bridges J, Marshall CJ, Sahai E. Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo. Br J Cancer 2005;92:102-112
22. Thomson S, Petti F, Sujka-Kwok I, et al. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 2011;28:137-155
23. Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer 2008;99:520-526
24. Rakha EA, Boyce RW, Abd El-Rehim D, et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005;18 1295-1304
25. Mogi A, Kuwano H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011;2011:583929
26. Houben R, Hesbacher S, Schmid CP, et al. High-level expression of wildtype p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays. PLoS ONE 2011;6:e22096
27. Swartz MJ, Batra SK, Varshney GC, et al. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 2002;117:791-796
28. López-Ferrer A, Curull V, Barranco C, et al. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 2001;24:22-29